Article Information
PubMed
Published By
History
- Received June 9, 2023
- Revision received September 14, 2023
- Accepted September 18, 2023
- Published online July 29, 2024.
Article Versions
- Previous version (November 20, 2023 - 04:21).
- Previous version (April 16, 2024 - 16:30).
- Previous version (April 17, 2024 - 01:54).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2024, The Authors This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/)
Author Information
- Dajana Tare1,
- Samuel Coenen2,
- An De Sutter3,
- Stefan Heytens3,
- Dirk Devroey4,
- Laetitia Buret5,
- Birgitte Schoenmakers1,
- Nicolas Delvaux1,
- Jan Y Verbakel1,
- Kris Bogaerts6 and
- Ann van den Bruel1,*
- 1 Academic Centre for General Practice, KU Leuven, Belgium
- 2 Centre for General Practice, Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerpen, Belgium
- 3 Department of Public Health and Primary Care, Ghent University, KU Leuven, Belgium
- 4 Primary Care, Vrije Universiteit Brussel, Ixelles, Belgium
- 5 Department of General Medicine, University of Liège, Liège, Belgium
- 6 Department of Public Health and Primary Care, I-BioStat, KU Leuven, Leuven, Belgium
- ↵
*For correspondence:
Ann van den Bruel, ann.vandenbruel{at}kuleuven.be
Article usage
Statistics from Altmetric.com
In this issue
The DAWN antivirals trial: process evaluation of a COVID-19 trial in general practice
LinkedInJump to section
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals
